LexisNexis® Legal Newsroom
Abbott Withdraws Diet Drug Meridia From U.S. Market

ABBOTT PARK, Ill. - (Mealey's) After an unfavorable assessment by a Food and Drug Administration expert committee regarding cardiovascular risk, Abbott Laboratories on Oct. 8 agreed with an FDA request to withdraw the weight-loss drug Meridia (sibutramine) from the U.S. market. The FDA said it...

Abbott Withdraws Diet Pill Meridia In United States, Canada

WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients with a history of heart disease. Companies have struggled...